What is Citius Oncology, Inc. Common Stock's Market Cap?

Citius Oncology, Inc. Common Stock's Market Cap is $86.4M, based on as-reported figures from SEC (XBRL) filings.

What is Citius Oncology, Inc. Common Stock's Enterprise Value?

Citius Oncology, Inc. Common Stock's Enterprise Value is $86.2M, based on as-reported figures from SEC (XBRL) filings.

What is Citius Oncology, Inc. Common Stock's Price / Sales?

Citius Oncology, Inc. Common Stock's Price / Sales is 12.2×, based on as-reported figures from SEC (XBRL) filings.

What is Citius Oncology, Inc. Common Stock's EV / Revenue?

Citius Oncology, Inc. Common Stock's EV / Revenue is 12.1×, based on as-reported figures from SEC (XBRL) filings.

What is Citius Oncology, Inc. Common Stock's Revenue (TTM)?

Citius Oncology, Inc. Common Stock's Revenue (TTM) is $7.1M, based on as-reported figures from SEC (XBRL) filings.

What is Citius Oncology, Inc. Common Stock's Net Income (TTM)?

Citius Oncology, Inc. Common Stock's Net Income (TTM) is -$46.1M, based on as-reported figures from SEC (XBRL) filings.

What is Citius Oncology, Inc. Common Stock's Diluted EPS (TTM)?

Citius Oncology, Inc. Common Stock's Diluted EPS (TTM) is -0.50, based on as-reported figures from SEC (XBRL) filings.

What is Citius Oncology, Inc. Common Stock's Net Debt?

Citius Oncology, Inc. Common Stock's Net Debt is -$153.5K, based on as-reported figures from SEC (XBRL) filings.

Citius Oncology, Inc. Common Stock (CTOR) Financial Statements

Citius Oncology, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG01163HLS8

XNAS · usd

0.93▲ 0.07 (8.03%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close0.86

Day's Range0.87 – 0.94

52-Week Range0.49 – 2.25

Volume220.8K

Avg Volume100.7K

Share Statistics

Shares Outstanding

Employees—

ExchangeXNAS

Listed2024-08-13

Share count as of August 13, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Citius Oncology, Inc. Common Stock (CTOR)

What is Citius Oncology, Inc. Common Stock's Market Cap?: Citius Oncology, Inc. Common Stock's Market Cap is $86.4M, based on as-reported figures from SEC (XBRL) filings.
What is Citius Oncology, Inc. Common Stock's Enterprise Value?: Citius Oncology, Inc. Common Stock's Enterprise Value is $86.2M, based on as-reported figures from SEC (XBRL) filings.
What is Citius Oncology, Inc. Common Stock's Price / Sales?: Citius Oncology, Inc. Common Stock's Price / Sales is 12.2×, based on as-reported figures from SEC (XBRL) filings.
What is Citius Oncology, Inc. Common Stock's EV / Revenue?: Citius Oncology, Inc. Common Stock's EV / Revenue is 12.1×, based on as-reported figures from SEC (XBRL) filings.
What is Citius Oncology, Inc. Common Stock's Revenue (TTM)?: Citius Oncology, Inc. Common Stock's Revenue (TTM) is $7.1M, based on as-reported figures from SEC (XBRL) filings.
What is Citius Oncology, Inc. Common Stock's Net Income (TTM)?: Citius Oncology, Inc. Common Stock's Net Income (TTM) is -$46.1M, based on as-reported figures from SEC (XBRL) filings.
What is Citius Oncology, Inc. Common Stock's Diluted EPS (TTM)?: Citius Oncology, Inc. Common Stock's Diluted EPS (TTM) is -0.50, based on as-reported figures from SEC (XBRL) filings.
What is Citius Oncology, Inc. Common Stock's Net Debt?: Citius Oncology, Inc. Common Stock's Net Debt is -$153.5K, based on as-reported figures from SEC (XBRL) filings.